New Approaches to Alcohol Treatment Emerge
The treatment of alcohol withdrawal and alcohol use disorder has seen significant advancements in recent years, with a shift toward patient-centered, non-stigmatizing care. A key principle in this approach is the importance of language, with presenters encouraging the elimination of stigmatizing terminology such as “abuse” from documentation, replacing it with terms like “unhealthy alcohol use.”
This subtle change can improve patient engagement, reduce bias, and align with modern standards of care. Approximately 50% of patients with unhealthy alcohol use experience some degree of withdrawal, with about 80% of these cases being uncomplicated and not life-threatening.
Alcohol Withdrawal Severity
The concept of “kindling” – where repeated withdrawal episodes increase the likelihood of severe withdrawal – is a critical pathophysiologic mechanism. Identifying patients at risk for severe or complicated withdrawal is essential, with the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) being a highly accurate tool.
A score of 4 or more on the PAWSS demonstrates excellent sensitivity and specificity for predicting severe withdrawal, enabling hospitalists to triage patients appropriately and initiate early, aggressive treatment when indicated. The Clinical Institute Withdrawal Assessment for Alcohol (CIWA) has historically been the standard for monitoring withdrawal symptoms, but it has significant limitations.
Monitoring and Treatment
The modified Minnesota Detoxification Scale (mMINDS) is a more objective and efficient alternative, validated across emergency, intensive care, and general medicine settings. Benzodiazepines remain the gold standard for alcohol withdrawal, acting on gamma-aminobutyric acid type A receptors to counteract the hyperexcitable state of withdrawal.
Related: Sorry, you have been blocked
Long-acting agents are generally preferred, with diazepam offering the fastest onset. Symptom-triggered therapy is favored over scheduled regimens in most cases, though front-loading strategies are recommended for patients with severe or high-risk withdrawal. Phenobarbital is increasingly used as an adjunct or alternative in severe cases.
Its dual mechanism – enhancing gamma-aminobutyric acid activity and inhibiting N-methyl-D-aspartate receptors – makes it particularly effective in refractory withdrawal. While evidence quality remains limited, studies suggest the use of phenobarbital helps reduce intensive care unit admissions and shortens hospital stays.
Medication for Alcohol Use Disorder
The session emphasized a shift toward patient-centered, non-stigmatizing care, improved risk stratification for alcohol withdrawal, and proactive initiation of medications for alcohol use disorder during hospitalization.
Hospitalization for alcohol withdrawal is a critical opportunity to start treatment for alcohol use disorder, and this should be offered routinely to all eligible patients to reduce mortality and readmissions. By using validated risk stratification tools, optimizing withdrawal management strategies, and consistently offering treatment, clinicians can significantly improve patient outcomes.
Dr. Beshay, an assistant professor of medicine, notes that hospitalists play a critical role in managing acute alcohol withdrawal and initiating long-term treatment for alcohol use disorder. The use of medications, in combination with counseling and support, can help patients achieve and maintain sobriety, and hospitalists can provide guidance on hospital nausea treatment during this process.
